Efficiency of Levilimab in patients with moderate and severe COVID-19

• Main Authors: Yu. M. Gomon (Author), V. V. Strizheletsky (Author), I. G. Ivanov (Author), Yu. E. Balykina (Author), M. V. Ermolyev (Author), A. S. Kolbin (Author), M. V. Livshits (Author), T. A. Usmanova (Author), A. M. Fakhrutdinova (Author), Yu. S. Konstantinova (Author), A. P. Gubanov (Author)
• Format: Book
• Published: IRBIS LLC, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: evaluation of the clinical and economic efficiency of using Levilimab in the treatment of moderate and severe COVID-19 based on real world data (RWD).Material and methods. A single-center observational retrospective case-control study was performed. According to the matching algorithm, 83...